Retinal Vein Occlusion (RVO): Outcomes of Anti-VEGF vs Steroid Treatment for Macular Edema
International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.288 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Alka Ravi und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy and a major cause of visual impairment worldwide. Macular edema is the principal cause of vision loss in RVO. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents and intravitreal corticosteroids are the most widely used treatment modalities for RVO-related macular edema. However, comparative clinical outcomes between these therapies remain a subject of ongoing clinical interest.
Aim
To compare the visual and anatomical outcomes of anti-VEGF therapy and intravitreal steroid treatment in patients with macular edema secondary to retinal vein occlusion.
Methods
A hospital-based prospective observational study was conducted at Government Medical College & Hospital, West Champaran, Bettiah, Bihar, India from 5th March 2025 to 25th February 2026. A total of 150 patients with RVO-associated macular edema were enrolled. Patients were divided into two treatment groups: anti-VEGF group (n=80) and steroid group (n=70). Outcomes assessed included best corrected visual acuity (BCVA), central macular thickness (CMT) measured by optical coherence tomography (OCT), and treatmentrelated adverse events over a 6-month follow-up period.
Results
Both treatment groups showed significant improvement in BCVA and reduction in CMT. The anti-VEGF group demonstrated a greater improvement in visual acuity (mean BCVA improvement 0.32 ± 0.09 logMAR) compared with the steroid group (0.25 ± 0.08 logMAR, p
Zitieren
APA
Ravi, A., Das, A., Keshav, P. K., & Thakur, R. (2026). Retinal Vein Occlusion (RVO): Outcomes of Anti-VEGF vs Steroid Treatment for Macular Edema. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.288
Vancouver
Ravi A, Das A, Keshav PK, Thakur R. Retinal Vein Occlusion (RVO): Outcomes of Anti-VEGF vs Steroid Treatment for Macular Edema. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.288
BibTeX
@article{Ravi2026,
author = {Ravi, Alka and Das, Anurag and Keshav, Prakash Kumar and Thakur, Ramakant},
title = {Retinal Vein Occlusion (RVO): Outcomes of Anti-VEGF vs Steroid Treatment for Macular Edema},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.288}
}
EUVIMED